Cargando…

Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma

Background: The kinesin Eg5, a mitosis-associated protein, is overexpressed in many cancers. Here we explored the clinical significance of Eg5 in hepatocellular carcinoma (HCC). Methods: HCC tissues from surgical resection were collected. Total RNA was prepared from tumorous and nontumorous parts. E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Yu-Yun, Sun, Nai-Yun, Jeng, Yung-Ming, Wu, Yao-Ming, Hsu, Chiun, Hsu, Chih-Hung, Hsu, Hey-Chi, Cheng, Ann-Lii, Lin, Zhong-Zhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303881/ https://www.ncbi.nlm.nih.gov/pubmed/34359867 http://dx.doi.org/10.3390/cells10071698

Ejemplares similares

Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2022)

Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy
por: Shen, Ying-Chun, et al.
Publicado: (2021)

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
por: Hsu, Chih-Hung, et al.
Publicado: (2014)

Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
por: Chen, Bang-Bin, et al.
Publicado: (2021)

Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
por: Chen, Bang-Bin, et al.
Publicado: (2021)

Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
por: Lin, Zhong-Zhe, et al.
Publicado: (2010)

Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size
por: Lin, Zhong-Zhe, et al.
Publicado: (2013)

Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2019)

Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma
por: Ou, Da-Liang, et al.
Publicado: (2015)

Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinoma
por: Lee, Jan-Mou, et al.
Publicado: (2022)

Overexpression of CTHRC1 in Hepatocellular Carcinoma Promotes Tumor Invasion and Predicts Poor Prognosis
por: Chen, Yu-Ling, et al.
Publicado: (2013)

An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma
por: Shen, Ying-Chun, et al.
Publicado: (2021)

HSP70 regulates Eg5 distribution within the mitotic spindle and modulates the cytotoxicity of Eg5 inhibitors
por: Fang, Chieh-Ting, et al.
Publicado: (2020)

Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells
por: Shao, Yu-Yun, et al.
Publicado: (2017)

S100P Expression Is a Novel Prognostic Factor in Hepatocellular Carcinoma and Predicts Survival in Patients with High Tumor Stage or Early Recurrent Tumors
por: Yuan, Ray-Hwang, et al.
Publicado: (2013)

Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway
por: Ou, Da-Liang, et al.
Publicado: (2013)

Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin
por: Ou, Da-Liang, et al.
Publicado: (2014)

Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma
por: Su, Yung-Yeh, et al.
Publicado: (2022)

Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
por: Ou, Da-Liang, et al.
Publicado: (2021)

Prognostic Factors for Pulmonary Metastasectomy in Hepatocellular Carcinoma
por: Kuo, Shuenn-Wen, et al.
Publicado: (2006)

The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases
por: Chiang, Yun, et al.
Publicado: (2015)

Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma
por: Liu, Wei-Lin, et al.
Publicado: (2014)

The Role of MbEGS1 and MbEGS2 in Methyleugenol Biosynthesis by Melaleuca bracteata
por: Lin, Yongsheng, et al.
Publicado: (2023)

Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness
por: Hsu, Che-Yu, et al.
Publicado: (2019)

Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10
por: Cheng, Wei, et al.
Publicado: (2017)

Biomarker identification of hepatocellular carcinoma using a methodical literature mining strategy
por: Chang, Nai-Wen, et al.
Publicado: (2017)

Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2018)

High Cytoplasmic Expression of Krüppel-like Factor 4 Is an Independent Prognostic Factor of Better Survival in Hepatocellular Carcinoma
por: Hsu, Hui-Ting, et al.
Publicado: (2014)

Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report
por: Lin, Chih-Wen, et al.
Publicado: (2009)

Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients
por: Liu, Can, et al.
Publicado: (2017)

Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective
por: Su, Yu-Wen, et al.
Publicado: (2017)

Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab
por: Hsu, Chiun, et al.
Publicado: (2022)

Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell Cytotoxicity
por: Tsai, Chiao-Ling, et al.
Publicado: (2023)

Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical Treatment
por: Yeh, Jen-Hao, et al.
Publicado: (2015)

The Prognostic Value of Cytokeratin and Sal-Like Protein 4 Expression in Hepatocellular Carcinoma and Intra-Hepatic Cholangiocarcinoma in Taiwan
por: Lai, Yih-Shyong, et al.
Publicado: (2018)

A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma
por: Hsu, Chia-Yang, et al.
Publicado: (2017)

B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma
por: Guo, Jhe-Cyuan, et al.
Publicado: (2022)

Prognosticators of hepatocellular carcinoma with intrahepatic vascular invasion
por: Lo, Yuan-Chen, et al.
Publicado: (2019)

Anterograde injection of low-dose urokinase salvages free anterolateral thigh flap: A case report of safe and effective treatment
por: Hsu, Shao-Yun, et al.
Publicado: (2017)

Upregulation of Endocan by Epstein-Barr Virus Latent Membrane Protein 1 and Its Clinical Significance in Nasopharyngeal Carcinoma
por: Yu, Ping-Hung, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cgv1v8upr3ehb7r7sdkqe85vdm